Provided by Tiger Fintech (Singapore) Pte. Ltd.

HBM HOLDINGS-B

8.600
+0.000
Volume:6.31M
Turnover:55.14M
Market Cap:7.18B
PE:306.59
High:8.850
Open:8.580
Low:8.520
Close:8.600
Loading ...

HK Movers|HK Pharma Stocks Shined. Zai Lab Up 15%; HBM Up 10%; Remegen Up 9%; Alphamab And Wuxi Bio Up 5%.

Tiger Newspress
·
14 Apr

HBM Plans Up to HK$200 Million Share Buyback; Shares Surge 12%

MT Newswires Live
·
11 Apr

BRIEF-HBM Holdings Intends To Repurchase Shares Of Co

Reuters
·
10 Apr

Hbm Holdings - Intends to Repurchase Shares of Co in Open Market From Time to Time up to HK$200 Mln

THOMSON REUTERS
·
10 Apr

Harbour Biomed Appoints Youchen Chen as Chief Financial Officer

THOMSON REUTERS
·
10 Apr

HBM Holdings' 2024 Profit Shrinks

MT Newswires Live
·
02 Apr

HBM Holdings Reports Full Year 2024 Earnings

Simply Wall St.
·
02 Apr

Harbour Biomed Reports Full Year 2024 Financial Results

THOMSON REUTERS
·
31 Mar

Press Release: Harbour BioMed Reports Full Year 2024 Financial Results

Dow Jones
·
31 Mar

Harbour BioMed Shares Soar on News of AstraZeneca Collaboration

Dow Jones
·
24 Mar

Stock Track | HBM Holdings Soars 11.62% on Strategic Partnership with AstraZeneca

Stock Track
·
24 Mar

HBM Holdings Jumps 10% As It Partners with AstraZeneca for Strategic Growth

Tiger Newspress
·
24 Mar

BRIEF-HBM Holdings To Issue To Astrazeneca Holdings Subscription Shares

Reuters
·
21 Mar

BRIEF-Harbour Biomed Enters Into Global Strategic Collaboration With Astrazeneca

Reuters
·
21 Mar

Hbm Holdings Ltd - Harbour Biomed to Receive $175 Million Upfront and up to $4.4 Billion in Milestones

THOMSON REUTERS
·
21 Mar

Harbour Biomed Enters Into Global Strategic Collaboration With AstraZeneca to Discover and Develop Next-Generation Therapeutic Antibodies

THOMSON REUTERS
·
21 Mar

Hbm Holdings Ltd - AstraZeneca to Acquire 9.15% Newly Issued Shares of Harbour Biomed

THOMSON REUTERS
·
21 Mar

Hbm Holdings - to Issue to AstraZeneca Holdings Subscription Shares at US$1.38 per Share

THOMSON REUTERS
·
21 Mar

Harbour Biomed Appoints DR. Ian Y. Liu as Global Head of Legal

THOMSON REUTERS
·
11 Mar

Harbour Biomed Appoints Michael D. Patten as Chief Strategy Officer

THOMSON REUTERS
·
11 Mar